Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
XL110
- Development stage
- Preclinical
- Lead developer
- XL-protein
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous
01
Overview
XL110 is a preclinical-stage, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist being developed by XL-protein for the treatment of type 2 diabetes. The molecule is a recombinant fusion protein consisting of exenatide (a synthetic version of the incretin mimetic exendin-4) and a PAS polypeptide sequence (comprising Proline, Alanine, and Serine). XL-protein's proprietary PASylation technology increases the hydrodynamic volume of the peptide, thereby reducing renal clearance and significantly extending its plasma half-life. This modification allows for a more convenient dosing schedule compared to native exenatide while maintaining its pharmacological activity, which includes stimulating glucose-dependent insulin secretion, inhibiting glucagon release, and slowing gastric emptying.
- Other names
- PAS-exenatidePASylated exenatide
02
Targets
Beyond the preview
Go deeper on XL110.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XL110.